ERBB2 and neoplasm: To directly test whether the progenitor subset of the luminal epithelium is resistant to ErbB2-initaited tumorigenesis, we injected RCAS-caErbB2 into both Krt6a-tva mice and MMTV-tva mice and compared their tumor latency.